Idea principal
In a pilot trial of 33 older adults with cognitive frailty, 91% (30/33) were retained and the smartphone programme raised walking time, step count and brisk walking time, with significant gains only in the intervention group. With 16 and 17 people and within-group tests only, these results are preliminary and need a larger, assessor-blinded trial.
Study design
Ensayo aleatorizado
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Cognitive frailty, physical frailty together with cognitive impairment, is an at-risk state, and moderate-to-vigorous physical activity (MVPA) may slow its progression. The authors tested whether an mHealth programme using Samsung Health and WhatsApp to encourage brisk walking is feasible and what it does to cognition, frailty, walking time and MVPA.
Población y método
Open-label, parallel-group pilot RCT with 1:1 permuted block randomization in people aged 60 and over with cognitive frailty and physical inactivity. The intervention group (n=16) received a conventional behavior change intervention plus an mHealth smartphone program; the control group (n=17) received the conventional intervention only. Outcomes were cognitive function, frailty, walking time and MVPA, with feasibility judged by recruitment, retention, participation and compliance. Within-group effects were tested separately with the Wilcoxon signed-rank test.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 199 people were approached and 33 eligible participants were randomized (recruitment rate 33%); median age was 71.0 years (IQR 9.0) and 85% (28/33) were women.
- 2Retention was 91% (30/33) and attendance at all face-to-face sessions was 100% (33/33); ActiGraph wearing compliance was 88% (58/66 days) and smartphone compliance 97% (54/56 days).
- 3Cognitive function improved significantly in both the intervention (P=.003) and the control (P=.009) groups.
- 4Only the intervention group had significant improvements in frailty (P=.005), walking time (P=.03), step count (P=.02), brisk walking time (P=.009), peak cadence (P=.003) and MVPA time (P=.02).
Límites e incertidumbre
- 1With 33 participants and only 16 and 17 per group, this pilot was not powered to prove effectiveness.
- 2The tests compared before and after within each group, not the groups against each other, so the intervention's added benefit is not directly tested.
- 3The trial was open-label, so participants and assessors knew the allocation; the authors call for an assessor-blinded trial.
- 4The sample was 85% women and recruitment was low (33%), so participants may not represent older adults with cognitive frailty more generally. This reading is based on the abstract only.
Relevancia práctica
For older people with early memory and strength problems, a smartphone-supported brisk walking programme looks workable and may nudge people to walk more. The cognitive gains appeared in both groups, so they cannot be credited to the app. Check with a clinician before starting a new exercise programme.
Tus datos
Step count, walking time and cadence are the kind of data this trial tracked, with an ActiGraph device and a smartphone. If you use a watch or phone, compare your weekly average of brisk walking minutes and steps against your own baseline on the same device, and expect day-to-day variation.
Cómo interpretar la evidencia
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Cognitive frailty is the coexistence of physical frailty and cognitive impairment and is an at-risk state for many adverse health outcomes. Moderate-to-vigorous physical activity (MVPA) is protective against the progression of cognitive frailty. Physical inactivity is common in older people, and brisk walking is a feasible form of physical activity that can enhance their MVPA. Mobile health (mHealth) employing persuasive technology has been successful in increasing the levels of physical activity in older people. However, its feasibility and effects on older people with cognitive frailty are unclear.
Objective
We aimed to identify the issues related to the feasibility of an mHealth intervention and the trial (ie, recruitment, retention, participation, and compliance) and to examine the effects of the intervention on cognitive function, physical frailty, walking time, and MVPA.
Methods
An open-label, parallel design, randomized controlled trial (RCT) was employed. The eligibility criteria for the participants were age ≥60 years, having cognitive frailty, and having physical inactivity. In the intervention group, participants received both conventional behavior change intervention and mHealth (ie, smartphone-assisted program using Samsung Health and WhatsApp) interventions. In the control group, participants received conventional behavior change intervention only. The outcomes included cognitive function, frailty, walking time, and MVPA. Permuted block randomization in 1:1 ratio was used. The feasibility issue was described in terms of participant recruitment, retention, participation, and compliance. Wilcoxon signed-rank test was used to test the within-group effects in both groups separately.
Results
We recruited 99 participants; 33 eligible participants were randomized into either the intervention group (n=16) or the control (n=17) group. The median age was 71.0 years (IQR 9.0) and the majority of them were females (28/33, 85%). The recruitment rate was 33% (33/99), the participant retention rate was 91% (30/33), and the attendance rate of all the face-to-face sessions was 100% (33/33). The majority of the smartphone messages were read by the participants within 30 minutes (91/216, 42.1%). ActiGraph (58/66 days, 88%) and smartphone (54/56 days, 97%) wearing compliances were good. After the interventions, cognitive function improvement was significant in both the intervention (P=.003) and the control (P=.009) groups. The increase in frailty reduction (P=.005), walking time (P=.03), step count (P=.02), brisk walking time (P=.009), peak cadence (P=.003), and MVPA time (P=.02) were significant only in the intervention group.
Conclusions
Our mHealth intervention is feasible for implementation in older people with cognitive impairment and is effective at enhancing compliance with the brisk walking training program delivered by the conventional behavior change interventions. We provide preliminary evidence that this mHealth intervention can increase MVPA time to an extent sufficient to yield clinical benefits (ie, reduction in cognitive frailty). A full-powered and assessor-blinded RCT should be employed in the future to warrant these effects.
Trial registration
HKU Clinical Trials Registry HKUCTR-2283; http://www.hkuctr.com/Study/Show/31df4708944944bd99e730d839db4756.
Fuentes y atribución
Effects of an mHealth Brisk Walking Intervention on Increasing Physical Activity in Older People With Cognitive Frailty: Pilot Randomized Controlled Trial.
Kwan RY, Lee D, Lee PH, Tse M, Cheung DS, Thiamwong L, Choi KS.
JMIR mHealth and uHealth · 2020-07-31
DOI: 10.2196/16596 ↗PubMed · 32735218 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Exercise gave small-to-moderate cognitive gains across 133 reviews of trials
An umbrella review of 133 systematic reviews (2724 trials, 258,279 participants) found that exercise improved general cognition (SMD 0.42, 95% CI 0.37 to 0.47), memory (0.26) and executive function (0.24), with the largest memory gains in children and adolescents and the largest executive function gains in people with ADHD. Most of the reviews (94) were rated critically low in quality and the effects were smaller in the best-rated ones (0.23 for general cognition), and the outcomes were test scores, not dementia.
British Journal of Sports Medicine
More daily steps linked to fewer depressive symptoms across 33 studies of adults
Pooling 33 observational studies of 96,173 adults, higher daily step counts went with fewer depressive symptoms, and in the two prospective cohorts that could be pooled, 7000 or more steps a day went with a lower risk of depression than fewer (RR 0.69, 95% CI 0.62-0.77). Most studies were cross-sectional, so low mood may be reducing steps as much as steps affect mood, and the authors say the prediction intervals call for caution.
JAMA Network Open
Exercise eased depression in 218 trials, but confidence in the evidence is low
In a network meta-analysis of 218 trials with 14,170 people who met criteria for major depression, walking or jogging, yoga, strength training, mixed aerobic exercise and tai chi or qigong each gave moderate reductions in depression compared with active controls (walking or jogging: Hedges' g −0.62, 95% credible interval −0.80 to −0.45). Confidence in the evidence was low for walking or jogging and very low for the other treatments, mainly because only one study met the low-risk-of-bias criteria.
BMJ
Physical activity eased depression and anxiety across 97 reviews of trials
Across 97 systematic reviews that pooled 1039 randomized trials with 128,119 participants, physical activity had medium effects on depression (median effect size −0.43) and anxiety (−0.42) compared with usual care, and higher-intensity activity went with larger gains. Most of those reviews (77) were rated critically low in quality, and the evidence mainly concerns mild-to-moderate symptoms.
British Journal of Sports Medicine

